Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.
Liu S, Qi Y, Ge Y, Duplessis T, Rowan BG, Ip C, Cheng H, Rennie PS, Horikawa I, Lustig AJ, Yu Q, Zhang H, Dong Y.
Liu S, et al. Among authors: zhang h.
Mol Cancer Ther. 2010 Jul;9(7):2016-25. doi: 10.1158/1535-7163.MCT-09-0924. Epub 2010 Jun 22.
Mol Cancer Ther. 2010.
PMID: 20571066
Free PMC article.